Treatment options for the frail elderly depend on a number of factors, including level of function and capacity to manage their disease. Physicians should provide appropriate medical treatment tailored to individual patient needs.
With good multidisciplinary services, frail elderly have relatively low risk of mortality and hospitalization even when their functional status is severely compromised. Elderly can not be cured. They need long-term follow-up, and palliative care is recommended to reduce their quality of life for the best benefit to them and their family members.
The FRAIL can help you screen for frail elderly patients at the hospital if you find them presenting with signs of frailty. Other symptoms such as weakness and exhaustion have been used as diagnostic criteria for frail elderly patients but they may not be exclusive.
We estimated that about 13% of the population are frail elderly. For frail elderly women, the prevalence was 10% higher than that for frail elderly men. Our analysis was limited by the sample used and nonresponse rates were high.
The most important predictors of frailty, at the start of the study, could be the prevalence of major comorbidities. Older subjects should be identified and screened for frailty and comorbidities.
Compared with non-frail elderly, frail elderly have a higher risk of mortality and poorer health-related quality of life. Despite different clinical and social characteristics, frail elderly still have to receive the same kind of care, like home care, as other elderly who do not suffer frailty.
Transition interventions, such as transition planning, support and supervision, were frequently used in combination with health promotion, rehabilitation and medication. Future research could help us understand whether combined transition interventions and other treatments can influence the transition process.
Transition intervention (TAU) is more effective in improving the quality of care transitions than a control (TAU+TC+TC). This result has implications for practice and policy implications for transitions of end-of-life care and for the effectiveness of medical transitions services including discharge planning.
It is difficult to ascertain whether the studies that were conducted on frail elderly showed positive or negative results. Future, well-designed and well-managed trials, aiming to understand the effectiveness of intervention strategies for treating frail elders with a variety of treatment strategies to prevent and treat specific illness conditions need to be conducted in large and well-controlled trials with the help of clinical psychologists and Geriatrics experts. The studies have also been conducted on the effectiveness of interventions specifically directed against the risk of falls in frail elders.
This trial is a great opportunity to explore the impact of a structured transition intervention on outcomes of frail elderly patients admitted to a palliative care hospital.
No direct evidence of familial aggregation was found. Therefore, in this frail elderly population, there is no evidence to prove that a familial genetic predisposition and familial aggregation is associated.
Contrary to the common belief of some clinicians, a high percentage of frail patients are not at increased risk of deterioration, even when they are hospitalized with a number of comorbid conditions that are potentially fatal. Older, frail patients with multiple chronic diseases should not be excluded from research or medical treatment programs by the simple criteria of their age. The elderly are equally likely to benefit from care and research as young patients. In a large-scale prospective cohort study of older patients undergoing clinical research, the risk of death in frail elderly patients did not increase.